Abstract Aim The “2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management
of Patients With Atrial Fibrillation” provides recommendations to guide clinicians in the …

Supraventricular tachycardia (SVT) is a frequent complication of pulmonary hypertension
(PH). The most prevalent SVTs are atrial fibrillation (AF) and typical atrial flutter (AFL) …

Chronic thrombo-embolic pulmonary hypertension (CTEPH) develops in a subset of patients
after acute pulmonary embolism. In CTEPH, pulmonary vascular resistance, which is initially …

Purpose Patients with pulmonary hypertension (PH) frequently suffer from supraventricular
tachycardias (SVT). The main purpose of our study was to identify the cumulative incidence …

Atrial arrhythmias are a hallmark of heart diseases. The antiarrhythmic drug ranolazine with
multichannel blocker properties is a promising agent to treat atrial arrhythmias. We therefore …

Background We aimed to analyze the burden and predictors of arrhythmias and in-hospital
mortality in chronic obstructive pulmonary disease (COPD)-related hospitalizations using the …

Aims Right heart disease (RHD), characterized by right ventricular (RV) and atrial (RA)
hypertrophy, and cardiomyocytes'(CM) dysfunctions have been described to be associated …

Background Cardiac arrhythmias are considered a prominent phenomenon in patients with
pulmonary hypertension (PH). Older studies reported that 8% to 35% of patients with PH had …

Background The development of atrial flutter and fibrillation (AFL/AF) in patients with pre-
capillary pulmonary hypertension has been associated with an increased risk of morbidity …

Atrial arrhythmias (AA) are common in pulmonary hypertension (PH) and are closely
associated with poor clinical outcomes. One of the most studied models to investigate PH is …